Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia.

CONCLUSIONS: This is the first report of a novel abciximab/heparin protocol for LVAD implantation in patients with HIT. The preliminary results suggest the feasibility and safety of this protocol.
PMID: 28987395 [PubMed - as supplied by publisher]

Source: The Annals of Thoracic Surgery - October 4, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Lee CL, Colombo PC, Eisenberger A, Diuguid D, Jennings DL, Han J, Salna MP, Takeda K, Kurlansky PA, Yuzefpolskaya M, Garan AR, Naka Y, Takayama H Tags: Ann Thorac Surg Source Type: research